ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
23.084,69
3,38%
S&P 500
5.782,35
0,07%
Dow Jones
42.660,18
0,33%
Euro vs US Dollar
1,07493
1,18%
Bitcoin
88.488,37
1,46%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Alzamend Neuro Inc (ALZN) Börsenkurse

Alzamend Neuro Inc

Alzamend Neuro Inc (ALZN)

NASDAQ
0,7479
0,0229
( 3,16% )
Aktualisiert: 16:18:07
Verzögert um 15 Minuten
Fortg. Diagramm

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
0,7479
Gebot
0,73
Fragen
0,746
Volumen
33.330
0,70 Tagesbereich 0,748
0,6851 52-Wochen-Bereich 15,06
Marktkapitalisierung
4,063M
Handelsende
0,725
Handelsbeginn
0,73
Letzte Trade
5
@
0.745999
Letzter Handelszeitpunkt
16:28:43
Finanzvolumen
US$ 24.384
VWAP
0,73159
Durchschnittliches Volumen (3 Mio.)
396.431
Ausgegebene Aktien
5.432.797
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,40
Gewinn pro Aktie (EPS)
-1,83
Erlöse
-
Nettogewinn
-9,95M

Über Alzamend Neuro Inc

Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipe... Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.alzamend.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Alzamend Neuro Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALZN. The last closing price for Alzamend Neuro was US$0,73. Over the last year, Alzamend Neuro shares have traded in a share price range of US$ 0,6851 to US$ 15,06.

Alzamend Neuro currently has 5.432.797 shares in issue. The market capitalisation of Alzamend Neuro is US$3,94 million. Alzamend Neuro has a price to earnings ratio (PE ratio) of -0.40.

ALZN Neueste Nachrichten

Weitere Nachrichten

Form PRE 14A - Other preliminary proxy statements
Edgar (US Regulatory)
28 Februar 2025
ALZN (3,16%)

Form 8-K - Current report
Edgar (US Regulatory)
12 Dezember 2024
ALZN (3,16%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
11 Dezember 2024
ALZN (3,16%)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.1202-13.84633106780.86810.9260.68511395960.79928211CS
4-0.4021-34.96521739131.151.190.68518955601.00058974CS
12-0.4921-39.6854838711.241.340.68513964311.03661541CS
26-1.6521-68.83752.42.470.68513070971.30355677CS
52-9.0521-92.36836734699.815.060.68515838564.45557701CS
156-170.2521-99.56263157891712250.685145307479.64722524CS
260-4349.2521-99.982806896643505032.50.68511094155361.97103546CS

ALZN - Frequently Asked Questions (FAQ)

What is the current Alzamend Neuro share price?
The current share price of Alzamend Neuro is US$ 0,7479
How many Alzamend Neuro shares are in issue?
Alzamend Neuro has 5.432.797 shares in issue
What is the market cap of Alzamend Neuro?
The market capitalisation of Alzamend Neuro is USD 3,94M
What is the 1 year trading range for Alzamend Neuro share price?
Alzamend Neuro has traded in the range of US$ 0,6851 to US$ 15,06 during the past year
What is the PE ratio of Alzamend Neuro?
The price to earnings ratio of Alzamend Neuro is -0,4
What is the reporting currency for Alzamend Neuro?
Alzamend Neuro reports financial results in USD
What is the latest annual profit for Alzamend Neuro?
The latest annual profit of Alzamend Neuro is USD -9,95M
What is the registered address of Alzamend Neuro?
The registered address for Alzamend Neuro is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Alzamend Neuro website address?
The website address for Alzamend Neuro is www.alzamend.com
Which industry sector does Alzamend Neuro operate in?
Alzamend Neuro operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
GVVisionary Holdings Inc
US$ 2,30
(78,29%)
78,74M
CMRXChimerix Inc
US$ 8,405
(69,46%)
92,64M
ARBBARB IOT Group Ltd
US$ 0,792651
(52,43%)
52,26M
CDXCChromaDex Corporation
US$ 8,4986
(51,76%)
6,31M
PRTSCarParts com Inc
US$ 1,215
(37,88%)
4,25M
CUTRCutera Inc
US$ 0,1666
(-47,01%)
5,71M
LBGJLi Bang International Corporation Inc
US$ 1,30
(-35,00%)
114,77k
XCURExicure Inc
US$ 10,515
(-26,37%)
65,75k
CRWLGranite Shares 2x Long CRWD Daily ETF
US$ 22,90
(-21,06%)
276,91k
TIVCTivic Health Systems Inc
US$ 0,2741
(-19,36%)
796,03k
ADTXAditxt Inc
US$ 0,055
(10,44%)
101,65M
CMRXChimerix Inc
US$ 8,41
(69,56%)
93,88M
GVVisionary Holdings Inc
US$ 2,2901
(77,53%)
82,22M
NVDANVIDIA Corporation
US$ 115,54
(-0,39%)
73,88M
SLXNSilexion Therapeutics Corporation
US$ 1,425
(28,38%)
70,72M

ALZN Finanzen

Finanzen

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
ALZN
Alzamend Neuro
TG
A1919B
Valeo
USOTC
EVGGF
Evolution Gaming (PK)
TG
A28YPA
ABN AMRO Bank NV
BIT
I07263
INTESA SANPAOLO
TG
A28UXB
Vattenfall AB
LSE
0RC5
Prebet Aiud
TSX
HHLE
Harvest Healthcare Leade...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten